2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Insomnia: new trials by email Literature Review of Insomnia trials Research Report on Insomnia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence Suvorexant 20 mg, placebo - Insomnia, Alcohol Use Disorder | Phase 2 | Terminated | The Florey Institute of Neuroscience and Mental Health | 22 | 2019-08-26 | 2023-02-15 |
| Investigation of the Efficacy and Safety of CHI-921 in Insomnia. CHI-921, Placebo - Insomnia | Phase 2 | Terminated | Canopy Growth Corporation | 21 | 2019-03-21 | 2020-10-05 |
Sleep Initiation and Maintenance Disorders (2) · Alcoholism (1) · Marijuana Abuse (1)
Chemically-Induced Disorders (2) · Dyssomnias (2) · Mental Disorders (2) · Nervous System Diseases (2) · Sleep Disorders, Intrinsic (2) · Sleep Wake Disorders (2) · Substance-Related Disorders (2) · Alcohol-Related Disorders (1)
suvorexant (1)
Canopy Growth Corporation (1) · The Florey Institute of Neuroscience and Mental Health (1)
Australia (1) · Canada (1)
Andrew Lawrence (1) · Dr M Ware, MD (1) · Yvonne Bonomo (1)